Frazier Life Sciences Management
APLT icon

Frazier Life Sciences Management’s Applied Therapeutics APLT Stock Holding History

Frazier Life Sciences Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,286,135
Closed -$10.7M – 55
2024
Q2 		$10.7M Buy
2,286,135
+333,278
+17% +$1.58M 0.5% 35
2024
Q1 		$13.3M Buy
+1,952,857
New +$8.77M 0.56% 38

Other funds holding APLT

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Frazier Life Sciences Management's APLT Position: Q3 2024 in Review

Frazier Life Sciences Management sold out of Applied Therapeutics (APLT) in Q3 2024, closing a stake of 2,286,135 shares — an estimated $10.7M sold.

Frazier Life Sciences Management first reported a position in APLT in Q1 2024 and held it in 2 quarters. The position peaked at $13.3M in Q1 2024. 126 funds tracked by Wall St. Rank hold APLT as of Q3 2024.

  • Frazier Life Sciences Management reported no remaining Applied Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Frazier Life Sciences Management sold 2,286,135 Applied Therapeutics shares in Q3 2024, an estimated $10.7M.
  • Frazier Life Sciences Management first reported a position in Applied Therapeutics in Q1 2024 and held it in 2 quarters.
  • Frazier Life Sciences Management's Applied Therapeutics position peaked at $13.3M in Q1 2024.
  • 126 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2024.

Based on Frazier Life Sciences Management's 13F filing for Q3 2024, filed 15 Nov 2024.